Titre :
  • Extraskeletal benefits and risks of calcium, vitamin D and anti-osteoporosis medications.
Auteur : Body, Jean-Jacques ; Bergmann, Pierre ; Boonen, Steven ; Devogelaer, J.-P. ; Gielen, E ; Goemaere, Stefan ; Kaufman, J.-M. ; Rozenberg, Serge ; Reginster, Jean-Yves
Informations sur la publication : Osteoporosis international, 23 Suppl 1, (page S1-23)
Statut de publication : Publié, 2012-02
Sujet CREF : Sciences bio-médicales et agricoles
Mots-clés : Bisphosphonate
Calcium
Denosumab
Osteoporosis
SERM
Strontium ranelate
Vitamin D
Mots-clés MeSH : Aged
Antibodies, Monoclonal -- pharmacology
Antibodies, Monoclonal, Humanized
Bone Density Conservation Agents -- pharmacology -- therapeutic use
Calcium -- pharmacology -- therapeutic use
Cardiovascular Diseases -- chemically induced
Consensus
Dietary Supplements -- adverse effects
Diphosphonates -- pharmacology -- therapeutic use
Female
Humans
Male
Middle Aged
Muscle, Skeletal -- drug effects
Neoplasms -- chemically induced
Organometallic Compounds -- pharmacology
Osteoporosis -- drug therapy
Selective Estrogen Receptor Modulators -- pharmacology -- therapeutic use
Stroke -- chemically induced
Thiophenes -- pharmacology
Vitamin D -- pharmacology -- therapeutic use
Note : Journal Article
Research Support, Non-U.S. Gov't
SCOPUS: ar.j
Langue :
  • Anglais
Identificateurs : urn:issn:0937-941X 
info:doi/10.1007/s00198-011-1891-8
info:pmid/22311111
info:pmcid/PMC3273686